Risk factors and outcomes of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa: a clinical case-control study Source: International Congress 2017 – Respiratory infections in critically ill and immuno-depressed patientes Year: 2017
Clinical and microbiological characteristics of Pseudomonas aeruginosa isolates from patients with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 58s Year: 2005
Clinical outcomes of the patients with multidrug-resistant Acinetobacter baumannii pneumonia in critical care setting: A retrospective cohort study in Taiwan Source: International Congress 2018 – Preclinical and clinical studies of critical illness Year: 2018
Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: a multinational point prevalence study of hospitalised patients Source: Eur Respir J, 52 (2) 1701190; 10.1183/13993003.01190-2017 Year: 2018
Prognosis of Acinetobacter baumannii bacteraemia in a respiratory ICU: 10 years‘ experience Source: Eur Respir J 2005; 26: Suppl. 49, 222s Year: 2005
Community acquired legionella pneumophila pneumonia, clinical characteristics, outcomes and prognostic factors Source: International Congress 2015 – Clinical issues in CAP: microbiological and radiological determinants Year: 2015
Pneumonia caused by extensive drug-resistant Acinetobacter baumannii among hospitalized patients: genetic relationships, risk factors and mortality Source: International Congress 2017 – Respiratory infections in critically ill and immuno-depressed patientes Year: 2017
Clinical profile and outcome of patients with sputum positive Acinetobacter baumanni infection Source: International Congress 2018 – Difficult-to-treat respiratory infections Year: 2018
Clinical characteristics of the patients with community-acquired Legionella pneumonia in advanced age Source: Eur Respir J 2005; 26: Suppl. 49, 410s Year: 2005
Predictive factors for true bacteremia and clinical utility of blood cultures as a prognostic tool in patients with community-onset pneumonia Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues Year: 2016
Clinical features, outcome and factors associated with mortality in patients with Nocardia pneumonia Source: Annual Congress 2012 - Viral infections and rare respiratory infections Year: 2012
An experience of moxifloxacin (MOX) use in therapy of nosocomial pneumonia (NP) in patients who hadn‘t risk factors to be infected by Pseudomonas aeruginosa Source: Eur Respir J 2005; 26: Suppl. 49, 187s Year: 2005
Community-acquired pneumonia in the elderly: Spanish multicentre study Source: Eur Respir J 2003; 21: 294-302 Year: 2003
Incidence, characteristics and outcomes of patients with severe community acquired-MRSA pneumonia Source: Eur Respir J 2009; 34: 1148-1158 Year: 2009
Community acquired pneumonia in the elderly: clinical aspects and prognostic factors Source: Eur Respir J 2006; 28: Suppl. 50, 352s Year: 2006
Bacterial features of bacteremia in pediatric patients with pneumonia at Children hospital No. 1, Vietnam Source: International Congress 2019 – Paediatric respiratory infections around the world: Tuberculosis, pneumonia and others Year: 2019
Could nan1-expression and production by pseudomonas aeruginosa be a prognostic factor for survival in CF patients Source: International Congress 2016 – Cystic fibrosis: inflammation, microbiology, management and monitoring Year: 2016
Carbapenems for the treatment of immunocompetent adult patients with nosocomial pneumonia Source: Eur Respir J 2007; 29: 548-560 Year: 2007
Pseudomonas aeruginosa colonisation in patients without bronchiectasisSource: International Congress 2014 – Clinical management of lung diseases: from bronchi to pleura Year: 2014
Clinical characteristics, outcomes and factors associated with mortality in nocardia pneumonia: 10 year experience from a developing country Source: International Congress 2019 – Pleural infection and complicated pneumonia Year: 2019